Farther Finance Advisors
IMNM icon

Farther Finance Advisors’s Immunome IMNM Stock Holding History

Farther Finance Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$323 Hold
15
– – ﹤0.01% 5812
2026
Q2 		$316 Sell
15
-1,984
-99% -$42.5K ﹤0.01% 5627
2026
Q1 		$44.9K Buy
1,999
+1,984
+13,227% +$44.2K ﹤0.01% 3070
2025
Q4 		$322 Buy
+15
New +$263 ﹤0.01% 5119
2025
Q2 		– Sell
-100
Closed -$626 – 4577
2025
Q1 		$626 Hold
100
– – ﹤0.01% 3738
2024
Q4 		$1.06K Hold
100
– – ﹤0.01% 3233
2024
Q3 		$1.46K Hold
100
– – ﹤0.01% 3108
2024
Q2 		$1.22K Hold
100
– – ﹤0.01% 2996
2024
Q1 		$2.21K Hold
100
– – ﹤0.01% 2449
2023
Q4 		$1.07K Hold
100
– – ﹤0.01% 2696
2023
Q3 		$835 Hold
100
– – ﹤0.01% 2124
2023
Q2 		$791 Hold
100
– – ﹤0.01% 2037
2023
Q1 		$499 Hold
100
– – ﹤0.01% 2006
2022
Q4 		$221 Buy
+100
New +$403 ﹤0.01% 2021

Other funds holding IMNM

MWM
Maltin Wealth Management Ridgewood, New Jersey $308M AUM 16.5% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's IMNM Position: Q3 2026 in Review

Farther Finance Advisors held its Immunome (IMNM) position steady in Q3 2026 at 15 shares worth $323. The position accounts for ﹤0.01% of the portfolio, ranked #5812.

Farther Finance Advisors first reported a position in IMNM in Q4 2022 and has held it in 14 quarters since. The position peaked at $44.9K in Q1 2026. 6 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Farther Finance Advisors held 15 shares of Immunome worth $323 as of Q3 2026.
  • Farther Finance Advisors left its Immunome share count unchanged in Q3 2026.
  • Immunome made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5812 holding.
  • Farther Finance Advisors first reported a position in Immunome in Q4 2022 and has held it in 14 quarters since.
  • Farther Finance Advisors's Immunome position peaked at $44.9K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.